APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Diagnostic Reagent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Disease Diagnostic Reagent Market Outlook and Growth Opportunities 2026

25 December 2025197 pages

Choose your research edition.

Industry ResearchPet Disease Diagnostic Reagent Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Diagnostic Reagent Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pet Disease Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Diagnostic Reagent Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Diagnostic Reagent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pet Disease Diagnostic Reagent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Disease Diagnostic Reagent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Disease Diagnostic Reagent market include Nanjing Synthgene Medical Technology, USTAR BIOTECHNOLOGIES (HANGZHOU), Hangzhou LifeReal Biotechnology, Harbin Guosheng Biomedical Laboratory, Idvet, IDEXX, Diogene and Bio-Rad, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Disease Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Disease Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Disease Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Disease Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Disease Diagnostic Reagent Segment by Company

Nanjing Synthgene Medical Technology

USTAR BIOTECHNOLOGIES (HANGZHOU)

Hangzhou LifeReal Biotechnology

Harbin Guosheng Biomedical Laboratory

Idvet

IDEXX

Diogene

Bio-Rad

Pet Disease Diagnostic Reagent Segment by Type

Nucleic Acid Detection Reagents

Colloidal Gold Detection Reagents

Enzyme-linked Immunosorbent Assay Reagents

Fluorescent PCR Detection Reagents

Pet Disease Diagnostic Reagent Segment by Application

Cat

Dog

Others

Pet Disease Diagnostic Reagent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Disease Diagnostic Reagent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Disease Diagnostic Reagent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Disease Diagnostic Reagent significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Disease Diagnostic Reagent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Disease Diagnostic Reagent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Disease Diagnostic Reagent industry.

Chapter 3: Detailed analysis of Pet Disease Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Disease Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Disease Diagnostic Reagent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Disease Diagnostic Reagent Industry Trends Table 2. Pet Disease Diagnostic Reagent Industry Drivers Table 3. Pet Disease Diagnostic Reagent Industry Opportunities and Challenges Table 4. Pet Disease Diagnostic Reagent Industry Restraints Table 5. Global Pet Disease Diagnostic Reagent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Disease Diagnostic Reagent Revenue Share by Company (2021-2026) Table 7. Global Pet Disease Diagnostic Reagent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pet Disease Diagnostic Reagent Sales Volume Share by Company (2021-2026) Table 9. Global Pet Disease Diagnostic Reagent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pet Disease Diagnostic Reagent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Disease Diagnostic Reagent Key Company Manufacturing Base & Headquarters Table 12. Global Pet Disease Diagnostic Reagent Company, Product Type & Application Table 13. Global Pet Disease Diagnostic Reagent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Disease Diagnostic Reagent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nucleic Acid Detection Reagents Table 18. Significant Companies of Colloidal Gold Detection Reagents Table 19. Significant Companies of Enzyme-linked Immunosorbent Assay Reagents Table 20. Significant Companies of Fluorescent PCR Detection Reagents Table 21. Global Pet Disease Diagnostic Reagent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Pet Disease Diagnostic Reagent Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Pet Disease Diagnostic Reagent Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Pet Disease Diagnostic Reagent Sales Volume Share by Type (2021-2026) Table 25. Global Pet Disease Diagnostic Reagent Sales Volume Share by Type (2027-2032) Table 26. Global Pet Disease Diagnostic Reagent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet Disease Diagnostic Reagent Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pet Disease Diagnostic Reagent Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pet Disease Diagnostic Reagent Sales Value Share by Type (2021-2026) Table 30. Global Pet Disease Diagnostic Reagent Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cat Table 32. Significant Companies of Dog Table 33. Significant Companies of Others Table 34. Global Pet Disease Diagnostic Reagent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Pet Disease Diagnostic Reagent Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Pet Disease Diagnostic Reagent Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Pet Disease Diagnostic Reagent Sales Volume Share by Application (2021-2026) Table 38. Global Pet Disease Diagnostic Reagent Sales Volume Share by Application (2027-2032) Table 39. Global Pet Disease Diagnostic Reagent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pet Disease Diagnostic Reagent Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pet Disease Diagnostic Reagent Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pet Disease Diagnostic Reagent Sales Value Share by Application (2021-2026) Table 43. Global Pet Disease Diagnostic Reagent Sales Value Share by Application (2027-2032) Table 44. Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Pet Disease Diagnostic Reagent Sales by Region (2021-2026) & (K Units) Table 46. Global Pet Disease Diagnostic Reagent Sales Market Share by Region (2021-2026) Table 47. Global Pet Disease Diagnostic Reagent Sales by Region (2027-2032) & (K Units) Table 48. Global Pet Disease Diagnostic Reagent Sales Market Share by Region (2027-2032) Table 49. Global Pet Disease Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pet Disease Diagnostic Reagent Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pet Disease Diagnostic Reagent Sales Value Share by Region (2021-2026) Table 52. Global Pet Disease Diagnostic Reagent Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pet Disease Diagnostic Reagent Sales Value Share by Region (2027-2032) Table 54. Global Pet Disease Diagnostic Reagent Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Pet Disease Diagnostic Reagent Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Pet Disease Diagnostic Reagent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Pet Disease Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pet Disease Diagnostic Reagent Sales by Country (2021-2026) & (K Units) Table 59. Global Pet Disease Diagnostic Reagent Sales Market Share by Country (2021-2026) Table 60. Global Pet Disease Diagnostic Reagent Sales by Country (2027-2032) & (K Units) Table 61. Global Pet Disease Diagnostic Reagent Sales Market Share by Country (2027-2032) Table 62. Global Pet Disease Diagnostic Reagent Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pet Disease Diagnostic Reagent Sales Value Market Share by Country (2021-2026) Table 64. Global Pet Disease Diagnostic Reagent Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pet Disease Diagnostic Reagent Sales Value Market Share by Country (2027-2032) Table 66. Nanjing Synthgene Medical Technology Company Information Table 67. Nanjing Synthgene Medical Technology Business Overview Table 68. Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio Table 70. Nanjing Synthgene Medical Technology Recent Development Table 71. USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information Table 72. USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview Table 73. USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio Table 75. USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Development Table 76. Hangzhou LifeReal Biotechnology Company Information Table 77. Hangzhou LifeReal Biotechnology Business Overview Table 78. Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio Table 80. Hangzhou LifeReal Biotechnology Recent Development Table 81. Harbin Guosheng Biomedical Laboratory Company Information Table 82. Harbin Guosheng Biomedical Laboratory Business Overview Table 83. Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio Table 85. Harbin Guosheng Biomedical Laboratory Recent Development Table 86. Idvet Company Information Table 87. Idvet Business Overview Table 88. Idvet Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Idvet Pet Disease Diagnostic Reagent Product Portfolio Table 90. Idvet Recent Development Table 91. IDEXX Company Information Table 92. IDEXX Business Overview Table 93. IDEXX Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. IDEXX Pet Disease Diagnostic Reagent Product Portfolio Table 95. IDEXX Recent Development Table 96. Diogene Company Information Table 97. Diogene Business Overview Table 98. Diogene Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Diogene Pet Disease Diagnostic Reagent Product Portfolio Table 100. Diogene Recent Development Table 101. Bio-Rad Company Information Table 102. Bio-Rad Business Overview Table 103. Bio-Rad Pet Disease Diagnostic Reagent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio Table 105. Bio-Rad Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Pet Disease Diagnostic Reagent Distributors List Table 109. Pet Disease Diagnostic Reagent Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Pet Disease Diagnostic Reagent Product Image Figure 2. Global Pet Disease Diagnostic Reagent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Disease Diagnostic Reagent Sales (2021-2032) & (K Units) Figure 5. Global Pet Disease Diagnostic Reagent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pet Disease Diagnostic Reagent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nucleic Acid Detection Reagents Image Figure 10. Colloidal Gold Detection Reagents Image Figure 11. Enzyme-linked Immunosorbent Assay Reagents Image Figure 12. Fluorescent PCR Detection Reagents Image Figure 13. Global Pet Disease Diagnostic Reagent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pet Disease Diagnostic Reagent Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Disease Diagnostic Reagent Sales Volume Share by Type (2021-2032) Figure 16. Global Pet Disease Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Disease Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Disease Diagnostic Reagent Sales Value Share by Type (2021-2032) Figure 19. Cat Image Figure 20. Dog Image Figure 21. Others Image Figure 22. Global Pet Disease Diagnostic Reagent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Pet Disease Diagnostic Reagent Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pet Disease Diagnostic Reagent Sales Volume Share by Application (2021-2032) Figure 25. Global Pet Disease Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pet Disease Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pet Disease Diagnostic Reagent Sales Value Share by Application (2021-2032) Figure 28. Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Pet Disease Diagnostic Reagent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pet Disease Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pet Disease Diagnostic Reagent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pet Disease Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pet Disease Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pet Disease Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pet Disease Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pet Disease Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pet Disease Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pet Disease Diagnostic Reagent Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pet Disease Diagnostic Reagent Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acid Detection Reagents
  • Colloidal Gold Detection Reagents
  • Enzyme-linked Immunosorbent Assay Reagents
  • Fluorescent PCR Detection Reagents
Applications
  • Cat
  • Dog
  • Others
Companies covered
  • Nanjing Synthgene Medical Technology
  • USTAR BIOTECHNOLOGIES (HANGZHOU)
  • Hangzhou LifeReal Biotechnology
  • Harbin Guosheng Biomedical Laboratory
  • Idvet
  • IDEXX
  • Diogene
  • Bio-Rad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  4. 1.2.2 Global Pet Disease Diagnostic Reagent Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Disease Diagnostic Reagent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Disease Diagnostic Reagent Market Dynamics
  1. 2.1 Pet Disease Diagnostic Reagent Industry Trends
  2. 2.2 Pet Disease Diagnostic Reagent Industry Drivers
  3. 2.3 Pet Disease Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Pet Disease Diagnostic Reagent Industry Restraints
3 Pet Disease Diagnostic Reagent Market by Company
  1. 3.1 Global Pet Disease Diagnostic Reagent Company Revenue Ranking in 2025
  2. 3.2 Global Pet Disease Diagnostic Reagent Revenue by Company (2021-2026)
  3. 3.3 Global Pet Disease Diagnostic Reagent Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Disease Diagnostic Reagent Average Price by Company (2021-2026)
  5. 3.5 Global Pet Disease Diagnostic Reagent Company Ranking (2024-2026)
  6. 3.6 Global Pet Disease Diagnostic Reagent Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Disease Diagnostic Reagent Company Product Type and Application
  8. 3.8 Global Pet Disease Diagnostic Reagent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Disease Diagnostic Reagent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Disease Diagnostic Reagent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Disease Diagnostic Reagent Market by Type
  1. 4.1 Pet Disease Diagnostic Reagent Type Introduction
  2. 4.1.1 Nucleic Acid Detection Reagents
  3. 4.1.2 Colloidal Gold Detection Reagents
  4. 4.1.3 Enzyme-linked Immunosorbent Assay Reagents
  5. 4.1.4 Fluorescent PCR Detection Reagents
  6. 4.2 Global Pet Disease Diagnostic Reagent Sales Volume by Type
  7. 4.2.1 Global Pet Disease Diagnostic Reagent Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet Disease Diagnostic Reagent Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pet Disease Diagnostic Reagent Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pet Disease Diagnostic Reagent Sales Value by Type
  11. 4.3.1 Global Pet Disease Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet Disease Diagnostic Reagent Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pet Disease Diagnostic Reagent Sales Value Share by Type (2021-2032)
5 Pet Disease Diagnostic Reagent Market by Application
  1. 5.1 Pet Disease Diagnostic Reagent Application Introduction
  2. 5.1.1 Cat
  3. 5.1.2 Dog
  4. 5.1.3 Others
  5. 5.2 Global Pet Disease Diagnostic Reagent Sales Volume by Application
  6. 5.2.1 Global Pet Disease Diagnostic Reagent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Disease Diagnostic Reagent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pet Disease Diagnostic Reagent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pet Disease Diagnostic Reagent Sales Value by Application
  10. 5.3.1 Global Pet Disease Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Disease Diagnostic Reagent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pet Disease Diagnostic Reagent Sales Value Share by Application (2021-2032)
6 Pet Disease Diagnostic Reagent Regional Sales and Value Analysis
  1. 6.1 Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Disease Diagnostic Reagent Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Disease Diagnostic Reagent Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Disease Diagnostic Reagent Sales by Region (2027-2032)
  5. 6.3 Global Pet Disease Diagnostic Reagent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Disease Diagnostic Reagent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Disease Diagnostic Reagent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Disease Diagnostic Reagent Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Disease Diagnostic Reagent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  12. 6.6.2 North America Pet Disease Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Disease Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Disease Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  21. 6.9.2 South America Pet Disease Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Disease Diagnostic Reagent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Disease Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
7 Pet Disease Diagnostic Reagent Country-level Sales and Value Analysis
  1. 7.1 Global Pet Disease Diagnostic Reagent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Disease Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Disease Diagnostic Reagent Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Disease Diagnostic Reagent Sales by Country (2027-2032)
  6. 7.4 Global Pet Disease Diagnostic Reagent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Disease Diagnostic Reagent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Disease Diagnostic Reagent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Disease Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Disease Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Disease Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nanjing Synthgene Medical Technology
  2. 8.1.1 Nanjing Synthgene Medical Technology Company Information
  3. 8.1.2 Nanjing Synthgene Medical Technology Business Overview
  4. 8.1.3 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio
  6. 8.1.5 Nanjing Synthgene Medical Technology Recent Developments
  7. 8.2 USTAR BIOTECHNOLOGIES (HANGZHOU)
  8. 8.2.1 USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information
  9. 8.2.2 USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview
  10. 8.2.3 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio
  12. 8.2.5 USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments
  13. 8.3 Hangzhou LifeReal Biotechnology
  14. 8.3.1 Hangzhou LifeReal Biotechnology Company Information
  15. 8.3.2 Hangzhou LifeReal Biotechnology Business Overview
  16. 8.3.3 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio
  18. 8.3.5 Hangzhou LifeReal Biotechnology Recent Developments
  19. 8.4 Harbin Guosheng Biomedical Laboratory
  20. 8.4.1 Harbin Guosheng Biomedical Laboratory Company Information
  21. 8.4.2 Harbin Guosheng Biomedical Laboratory Business Overview
  22. 8.4.3 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio
  24. 8.4.5 Harbin Guosheng Biomedical Laboratory Recent Developments
  25. 8.5 Idvet
  26. 8.5.1 Idvet Company Information
  27. 8.5.2 Idvet Business Overview
  28. 8.5.3 Idvet Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Idvet Pet Disease Diagnostic Reagent Product Portfolio
  30. 8.5.5 Idvet Recent Developments
  31. 8.6 IDEXX
  32. 8.6.1 IDEXX Company Information
  33. 8.6.2 IDEXX Business Overview
  34. 8.6.3 IDEXX Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 IDEXX Pet Disease Diagnostic Reagent Product Portfolio
  36. 8.6.5 IDEXX Recent Developments
  37. 8.7 Diogene
  38. 8.7.1 Diogene Company Information
  39. 8.7.2 Diogene Business Overview
  40. 8.7.3 Diogene Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Diogene Pet Disease Diagnostic Reagent Product Portfolio
  42. 8.7.5 Diogene Recent Developments
  43. 8.8 Bio-Rad
  44. 8.8.1 Bio-Rad Company Information
  45. 8.8.2 Bio-Rad Business Overview
  46. 8.8.3 Bio-Rad Pet Disease Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio
  48. 8.8.5 Bio-Rad Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Disease Diagnostic Reagent Value Chain Analysis
  2. 9.1.1 Pet Disease Diagnostic Reagent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Disease Diagnostic Reagent Sales Mode & Process
  6. 9.2 Pet Disease Diagnostic Reagent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Disease Diagnostic Reagent Distributors
  9. 9.2.3 Pet Disease Diagnostic Reagent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst